BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk

Cytokine and Growth Factor Reviews

Volumn 16, Issue 3 SPEC. ISS., 2005, Pages 251-263

  Miyazono, Kohei ^a,b   Maeda, Shingo ^b   Imamura, Takeshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

BMP; Serine threonine kinase receptor; Signaling cross talk; Smad; TGF

Indexed keywords

ACTIVIN; ASSOCIATED MOLECULE WITH SH 3 DOMAIN OF SIGNAL TRANSDUCING ADAPTOR MOLECULE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR; CELLULAR APOPTOSIS SUSCEPTIBILITY INTERACTING ZINC FINGER PROTEIN; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE 6; DNA; DROSOPHILA DACHSHUND NUCLEAR PROTEIN; E 3 LIGASE; EPIDERMAL GROWTH FACTOR; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE GCN5; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION 3; INHIBITOR OF DIFFERENTIATION 4; INHIBITORY SMAD PROTEIN; LIGASE; METHIONINE; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH1 RECEPTOR; NUCLEAR PROTEIN; OSTEOGENIC PROTEIN 1; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN; PROTEIN P300; PROTEIN SERINE THREONINE KINASE; PROTEIN SMURF 1; PROTEIN SMURF 2; RING PROTEIN; SMAD 1 PROTEIN ANTAGONISTIC EFFECTOR; SMAD PROTEIN; SMAD1 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; STAT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR YY 1; TRANSDUCER OF EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; ZINC FINGER PROTEIN;

CELL DIFFERENTIATION; CELL GROWTH; DNA BINDING; DNA MICROARRAY; DNA SEQUENCE; GENE IDENTIFICATION; GENE TARGETING; GENETIC TRANSCRIPTION; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; ONCOGENE; ONCOGENE SKI; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; XENOPUS;

EID: 21344455768     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2005.01.009     Document Type: Article

References (130)

1. K. Miyazawa, M. Shinozaki, T. Hara, T. Furuya, and K. Miyazono Two major Smad pathways in TGF-β superfamily signaling Genes Cells 7 2002 1191 1204
2. R. Derynck, R.J. Akhurst, and A. Balmain TGF-β signaling in tumor suppression and cancer progression Nat Genet 29 2001 117 129
3. Y. Shi, and J. Massague Mechanisms of TGF-β signaling from cell membrane to the nucleus Cell 113 2003 685 700
4. M. Kawabata, T. Imamura, and K. Miyazono Signal transduction by bone morphogenetic proteins Cytokine Growth Factor Rev 9 1998 49 61
5. K. Miyazono Bone morphogenetic protein receptors and actions J.P. Bilezikian L.G. Raisz GA. Rodan Principles of bone biology 2nd ed. 2002 Academic Press 929 942
6. C.H. Heldin, K. Miyazono, and P. ten Dijke TGF-β signaling from cell membrane to nucleus through SMAD proteins Nature 390 1997 465 471
7. K.B. Lane, R.D. Machado, M.W. Pauciulo, J.R. Thomson, J.A. Phillips III, and J.E. Loyd Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension Nat Genet 26 2000 81 84
8. Z. Deng, J.H. Morse, S.L. Slager, N. Cuervo, K.J. Moore, and G. Venetos Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene Am J Hum Genet 67 2000 737 744
9. J.R. Howe, J.L. Bair, M.G. Sayed, M.E. Anderson, F.A. Mitros, and G.M. Petersen Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis Nat Genet 28 2001 184 187
10. B.L. Rosenzweig, T. Imamura, T. Okadome, G.N. Cox, H. Yamashita, and P. ten Dijke Cloning and characterization of a human type II receptor for bone morphogenetic proteins Proc Natl Acad Sci USA 92 1995 7632 7636
11. V.C. Foletta, M.A. Lim, J. Soosairajah, A.P. Kelly, E.G. Stanley, and M. Shannon Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1 J Cell Biol 162 2003 1089 1098
12. R.D. Machado, N. Rudarakanchana, C. Atkinson, J.A. Flanagan, R. Harrison, and N.W. Morrell Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension Hum Mol Genet 12 2003 3277 3286
13. S. Hassel, A. Eichner, M. Yakymovych, U. Hellman, P. Knaus, and S. Souchelnytskyi Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry Proteomics 4 2004 1346 1358
14. J.A. Visser, R. Olaso, M. Verhoef-Post, P. Kramer, A.P. Themmen, and H.A. Ingraham The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling Mol Endocrinol 15 2001 936 945
15. T.R. Clarke, Y. Hoshiya, S.E. Yi, X. Liu, K.M. Lyons, and P.K. Donahoe Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression Mol Endocrinol 15 2001 946 959
16. S.P. Jamin, N.A. Arango, Y. Mishina, M.C. Hanks, and R.R. Behringer Requirement of Bmpr1a for Mullerian duct regression during male sexual development Nat Genet 32 2002 408 410
17. H. Aoki, M. Fujii, T. Imamura, K. Yagi, K. Takehara, and M. Kato Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction J Cell Sci 114 2001 1483 1489
18. K.H. Cheng, J.F. Ponte, and S. Thiagalingam Elucidation of epigenetic inactivation of SMAD8 in cancer using targeted expressed gene display Cancer Res 64 2004 1639 1646
19. T. Tsukazaki, T.A. Chiang, A.F. Davison, L. Attisano, and J.L. Wrana SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor Cell 95 1998 779 791
20. H.K. Lin, S. Bergmann, and P.P. Pandolfi Cytoplasmic PML function in TGF-β signaling Nature 431 2004 205 211
21. R.S. Peterson, R.A. Andhare, K.T. Rousche, W. Knudson, W. Wang, and J.B. Grossfield CD44 modulates Smad1 activation in the BMP-7 signaling pathway J Cell Biol 166 2004 1081 1091
22. K. Miyazono, P. ten Dijke, and C.H. Heldin TGF-β signaling by Smad proteins Adv Immunol 75 2000 115 157
23. J. Kim, K. Johnson, H.J. Chen, S. Carroll, and A. Laughon Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic Nature 388 1997 304 308
24. K. Kusanagi, H. Inoue, Y. Ishidou, H.K. Mishima, M. Kawabata, and K. Miyazono Characterization of a bone morphogenetic protein-responsive Smad-binding element Mol Biol Cell 11 2000 555 565
25. K.A. Henningfeld, S. Rastegar, G. Adler, and W. Knochel Smad1 and Smad4 are components of the bone morphogenetic protein-4 (BMP-4)-induced transcription complex of the Xvent-2B promoter J Biol Chem 275 2000 21827 21835
26. T. Lopez-Rovira, E. Chalaux, J. Massague, J.L. Rosa, and F. Ventura Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene J Biol Chem 277 2002 3176 3185
27. O. Korchynskyi, and P. ten Dijke Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter J Biol Chem 277 2002 4883 4891
28. T. Katagiri, M. Imada, T. Yanai, T. Suda, N. Takahashi, and R. Kamijo Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis Genes Cells 7 2002 949 960
29. E. Karaulanov, W. Knochel, and C. Niehrs Transcriptional regulation of BMP4 synexpression in transgenic Xenopus EMBO J 23 2004 844 856
30. Y. Ito, and K. Miyazono RUNX transcription factors as key targets of TGF-β superfamily signaling Curr Opin Genet Dev 13 2003 43 47
31. Y.W. Zhang, N. Yasui, K. Ito, G. Huang, M. Fujii, and J. Hanai A RUNX2/PEBP2αA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia Proc Natl Acad Sci USA 97 2000 10549 10554
32. K. Miyazono, S. Maeda, and T. Imamura Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins Oncogene 23 2004 4232 4237
33. S. Maeda, M. Hayashi, S. Komiya, T. Imamura, and K. Miyazono Endogenous TGF-β signaling suppresses maturation of osteoblastic mesenchymal cells EMBO J 23 2004 552 563
34. K.S. Lee, H.J. Kim, Q.L. Li, X.Z. Chi, C. Ueta, and T. Komori Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12 Mol Cell Biol 20 2000 8783 8792
35. K. Miyama, G. Yamada, T.S. Yamamoto, C. Takagi, K. Miyado, and M. Sakai A BMP-inducible gene, Dlx5, regulates osteoblast differentiation and mesoderm induction Dev Biol 208 1999 123 133
36. M.H. Lee, Y.J. Kim, H.J. Kim, H.D. Park, A.R. Kang, and H.M. Kyung BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-β1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression J Biol Chem 278 2003 34387 34394
37. H. Sowa, H. Kaji, G.N. Hendy, L. Canaff, T. Komori, and T. Sugimoto Menin is required for bone morphogenetic protein 2- and transforming growth factor β-regulated osteoblastic differentiation through interaction with Smads and Runx2 J Biol Chem 279 2004 40267 40275
38. K. Kurisaki, A. Kurisaki, U. Valcourt, A.A. Terentiev, K. Pardali, and P. ten Dijke Nuclear factor YY1 inhibits transforming growth factor β- and bone morphogenetic protein-induced cell differentiation Mol Cell Biol 23 2003 4494 4510
39. M. Pashmforoush, J.T. Lu, H. Chen, T.S. Amand, R. Kondo, and S. Pradervand Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block Cell 117 2004 373 386
40. K.H. Lee, S. Evans, T.Y. Ruan, and A.B. Lassar SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac-specific expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer Development 131 2004 4709 4723
41. D. Liu, B.L. Black, and R. Derynck TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3 Genes Dev 15 2001 2950 2966
42. K.A. Henningfeld, H. Friedle, S. Rastegar, and W. Knochel Autoregulation of Xvent-2B; direct interaction and functional cooperation of Xvent-2 and Smad1 J Biol Chem 277 2002 2097 2103
43. A. Hata, J. Seoane, G. Lagna, E. Montalvo, A. Hemmati-Brivanlou, and J. Massague OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways Cell 100 2000 229 240
44. X. Shi, X. Yang, D. Chen, Z. Chang, and X. Cao Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling J Biol Chem 274 1999 13711 13717
45. T.S. Yamamoto, C. Takagi, and N. Ueno Requirement of Xmsx-1 in the BMP-triggered ventralization of Xenopus embryos Mech Dev 91 2000 131 141
46. K. Verschueren, J.E. Remacle, C. Collart, H. Kraft, B.S. Baker, and P. Tylzanowski SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes J Biol Chem 274 1999 20489 20498
47. C. Rodriguez, L.J. Huang, J.K. Son, A. McKee, Z. Xiao, and H.F. Lodish Functional cloning of the proto-oncogene brain factor-1 (BF-1) as a Smad-binding antagonist of transforming growth factor-β signaling J Biol Chem 276 2001 30224 30230
48. J. Comijn, G. Berx, P. Vermassen, K. Verschueren, L. van Grunsven, and E. Bruyneel The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion Mol Cell 7 2001 1267 1278
49. Y.H. Jin, E.J. Jeon, Q.L. Li, Y.H. Lee, J.K. Choi, and W.J. Kim Transforming growth factor-β stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation J Biol Chem 279 2004 29409 29417
50. S. Itoh, J. Ericsson, J. Nishikawa, C.H. Heldin, and P. ten Dijke The transcriptional co-activator P/CAF potentiates TGF-β/Smad signaling Nucleic Acids Res 28 2000 4291 4298
51. K. Kahata, M. Hayashi, M. Asaka, U. Hellman, H. Kitagawa, and J. Yanagisawa Regulation of transforming growth factor-β and bone morphogenetic protein signaling by transcriptional coactivator GCN5 Genes Cells 9 2004 143 151
52. T. Ogata, J.M. Wozney, R. Benezra, and M. Noda Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells Proc Natl Acad Sci USA 90 1993 9219 9222
53. Y. Yokota, and S. Mori Role of Id family proteins in growth control J Cell Physiol 190 2002 21 28
54. A. Rawls, and E.N. Olson MyoD meets its maker Cell 89 1997 5 8
55. K. Nakashima, T. Takizawa, W. Ochiai, M. Yanagisawa, T. Hisatsune, and M. Nakafuku BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis Proc Natl Acad Sci USA 98 2001 5868 5873
56. M.J. Goumans, G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras, and P. ten Dijke Balancing the activation state of the endothelium via two distinct TGF-β type I receptors EMBO J 21 2002 1743 1753
57. F. Vinals, J. Reiriz, S. Ambrosio, R. Bartrons, J.L. Rosa, and F. Ventura BMP-2 decreases Mash1 stability by increasing Id1 expression EMBO J 23 2004 3527 3537
58. F. Vinals, and F. Ventura Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1 J Biol Chem 279 2004 45766 45772
59. O. Korchynskyi, K.J. Dechering, A.M. Sijbers, W. Olijve, and P. ten Dijke Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation J Bone Miner Res 18 2003 1177 1185
60. B.M. Clancy, J.D. Johnson, A.J. Lambert, S. Rezvankhah, A. Wong, and C. Resmini A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps Bone 33 2003 46 63
61. Y. Peng, Q. Kang, H. Cheng, X. Li, M.H. Sun, and W. Jiang Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling J Cell Biochem 90 2003 1149 1165
62. M. Kowanetz, U. Valcourt, R. Bergstrom, C.H. Heldin, and A. Moustakas Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor β and bone morphogenetic protein Mol Cell Biol 24 2004 4241 4254
63. D.S. de Jong, B.L. Vaes, K.J. Dechering, A. Feijen, J.M. Hendriks, and R. Wehrens Identification of novel regulators associated with early-phase osteoblast differentiation J Bone Miner Res 19 2004 947 958
64. A. Hanyu, Y. Ishidou, T. Ebisawa, T. Shimanuki, T. Imamura, and K. Miyazono The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling J Cell Biol 155 2001 1017 1027
65. A. Hata, G. Lagna, J. Massague, and A. Hemmati-Brivanlou Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor Genes Dev 12 1998 186 197
66. G. Murakami, T. Watabe, K. Takaoka, K. Miyazono, and T. Imamura Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads Mol Biol Cell 14 2003 2809 2817
67. S. Edlund, S. Bu, N. Schuster, P. Aspenstrom, R. Heuchel, and N.E. Heldin Transforming growth factor-β1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3 Mol Biol Cell 14 2003 529 544
68. H. Zhu, P. Kavsak, S. Abdollah, J.L. Wrana, and G.H. Thomsen A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation Nature 400 1999 687 693
69. Y. Zhang, C. Chang, D.J. Gehling, A. Hemmati-Brivanlou, and R. Derynck Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase Proc Natl Acad Sci USA 98 2001 974 979
70. X. Lin, M. Liang, and X.H. Feng Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling J Biol Chem 275 2000 36818 36822
71. S.X. Ying, Z.J. Hussain, and Y.E. Zhang Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation J Biol Chem 278 2003 39029 39036
72. S.D. Podos, K.K. Hanson, Y.C. Wang, and E.L. Ferguson The DSmurf ubiquitin-protein ligase restricts BMP signaling spatially and temporally during Drosophila embryogenesis Dev Cell 1 2001 567 578
73. P. Kavsak, R.K. Rasmussen, C.G. Causing, S. Bonni, H. Zhu, and G.H. Thomsen Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF β receptor for degradation Mol Cell 6 2000 1365 1375
74. T. Ebisawa, M. Fukuchi, G. Murakami, T. Chiba, K. Tanaka, and T. Imamura Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation J Biol Chem 276 2001 12477 12480
75. M. Horiki, T. Imamura, M. Okamoto, M. Hayashi, J. Murai, and A. Myoui Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia J Cell Biol 165 2004 433 445
76. A. Komuro, T. Imamura, M. Saitoh, Y. Yoshida, T. Yamori, and K. Miyazono Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1) Oncogene 23 2004 6914 6923
77. G. Kuratomi, A. Komuro, K. Goto, M. Shinozaki, K. Miyazawa, and K. Miyazono Neural precursor cell expressed, developmentally down-regulated 4-2 (NEDD4-2) negatively regulates transforming growth factor-β (TGF-β) signaling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor Biochem J 386 2005 461 470
78. M. Zhao, M. Qiao, B.O. Oyajobi, G.R. Mundy, and D. Chen E3 ubiquitin ligase Smurf1 mediates core-binding factor α1/Runx2 degradation and plays a specific role in osteoblast differentiation J Biol Chem 278 2003 27939 27944
79. M. Zhao, M. Qiao, S.E. Harris, B.O. Oyajobi, G.R. Mundy, and D. Chen Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo J Biol Chem 279 2004 12854 12859
80. W. Shi, C. Sun, B. He, W. Xiong, X. Shi, and D. Yao GADD34-PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor J Cell Biol 164 2004 291 300
81. D. Bennett, and L. Alphey PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster Nat Genet 31 2002 419 423
82. D. Koinuma, M. Shinozaki, A. Komuro, K. Goto, M. Saitoh, and A. Hanyu Arkadia amplifies TGF-β superfamily signaling through degradation of Smad7 EMBO J 22 2003 6458 6470
83. B.C. Kim, H.J. Lee, S.H. Park, S.R. Lee, T.S. Karpova, and J.G. McNally Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor β signaling by binding to Smad7 and promoting its degradation Mol Cell Biol 24 2004 2251 2262
84. M. Wan, X. Cao, Y. Wu, S. Bai, L. Wu, and X. Shi Jab1 antagonizes TGF-β signaling by inducing Smad4 degradation EMBO Rep 3 2002 171 176
85. F. Itoh, H. Asao, K. Sugamura, C.H. Heldin, P. ten Dijke, and S. Itoh Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads EMBO J 20 2001 4132 4142
86. N. Ikematsu, Y. Yoshida, J. Kawamura-Tsuzuku, M. Ohsugi, M. Onda, and M. Hirai Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases Oncogene 18 1999 7432 7441
87. Y. Yoshida, S. Tanaka, H. Umemori, O. Minowa, M. Usui, and N. Ikematsu Negative regulation of BMP/Smad signaling by Tob in osteoblasts Cell 103 2000 1085 1097
88. Y. Yoshida, A. von Bubnoff, N. Ikematsu, I.L. Blitz, J.K. Tsuzuku, and E.H. Yoshida Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling Mech Dev 120 2003 629 637
89. X. Liu, Y. Sun, R.A. Weinberg, and H.F. Lodish Ski/Sno and TGF-β signaling Cytokine Growth Factor Rev 12 2001 1 8
90. M. Mizuide, T. Hara, T. Furuya, M. Takeda, K. Kusanagi, and Y. Inada Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN J Biol Chem 278 2003 531 536
91. J.W. Wu, A.R. Krawitz, J. Chai, W. Li, F. Zhang, and K. Luo Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-β signaling Cell 111 2002 357 367
92. B.Y. Qin, S.S. Lam, J.J. Correia, and K. Lin Smad3 allostery links TGF-β receptor kinase activation to transcriptional control Genes Dev 16 2002 1950 1963
93. W. Wang, F.V. Mariani, R.M. Harland, and K. Luo Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells Proc Natl Acad Sci USA 97 2000 14394 14399
94. M. Takeda, M. Mizuide, M. Oka, T. Watabe, H. Inoue, and H. Suzuki Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski Mol Biol Cell 15 2004 963 972
95. L.S. da Graca, K.K. Zimmerman, M.C. Mitchell, M. Kozhan-Gorodetska, K. Sekiewicz, and Y. Morales DAF-5 is a Ski oncoprotein homolog that functions in a neuronal TGF β pathway to regulate C. elegans dauer development Development 131 2004 435 446
96. G. Mardon, N.M. Solomon, and G.M. Rubin dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila Development 120 1994 3473 3486
97. K. Wu, Y. Yang, C. Wang, M.A. Davoli, M. D'Amico, and A. Li DACH1 inhibits transforming growth factor-β signaling through binding Smad4 J Biol Chem 278 2003 51673 51684
98. W. Shi, H. Chen, J. Sun, C. Chen, J. Zhao, and Y.L. Wang Overexpression of Smurf1 negatively regulates mouse embryonic lung branching morphogenesis by specifically reducing Smad1 and Smad5 proteins Am J Physiol Lung Cell Mol Physiol 286 2004 293 300
99. L. Li, H. Xin, X. Xu, M. Huang, X. Zhang, and Y. Chen CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription Mol Cell Biol 24 2004 856 864
100. M. Wan, Y. Tang, E.M. Tytler, C. Lu, B. Jin, and S.M. Vickers Smad4 protein stability is regulated by ubiquitin ligase SCF β-TrCP1 J Biol Chem 279 2004 14484 14487
101. P.S. Lee, C. Chang, D. Liu, and R. Derynck Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling J Biol Chem 278 2003 27853 27863
102. X. Lin, M. Liang, Y.Y. Liang, F.C. Brunicardi, and X.H. Feng SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4 J Biol Chem 278 2003 31043 31048
103. J. Long, I. Matsuura, D. He, G. Wang, K. Shuai, and F. Liu Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT Proc Natl Acad Sci USA 100 2003 9791 9796
104. T. Ogasawara, H. Kawaguchi, S. Jinno, K. Hoshi, K. Itaka, and T. Takato Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6 Mol Cell Biol 24 2004 6560 6568
105. G.P. Raju, N. Dimova, P.S. Klein, and H.C. Huang SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1 J Biol Chem 278 2003 428 437
106. Z.J. Shen, T. Nakamoto, K. Tsuji, A. Nifuji, K. Miyazono, and T. Komori Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts J Biol Chem 277 2002 29840 29846
107. A.F. Candia, T. Watabe, S.H. Hawley, D. Onichtchouk, Y. Zhang, and R. Derynck Cellular interpretation of multiple TGF-β signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads Development 124 1997 4467 4480
108. T. Kadesch Notch signaling: a dance of proteins changing partners Exp Cell Res 260 2000 1 8
109. T. Iso, L. Kedes, and Y. Hamamori HES and HERP families: multiple effectors of the Notch signaling pathway J Cell Physiol 194 2003 237 255
110. N. Zamurovic, D. Cappellen, D. Rohner, and M. Susa Coordinated activation of notch, Wnt, and transforming growth factor-β signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity J Biol Chem 279 2004 37704 37715
111. J. Zavadil, L. Cermak, N. Soto-Nieves, and E.P. Bottinger Integration of TGF-β/Smad and Jagged1/Notch signaling in epithelial-to-mesenchymal transition EMBO J 23 2004 1155 1165
112. C. Dahlqvist, A. Blokzijl, G. Chapman, A. Falk, K. Dannaeus, and C.F. Ibanez Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation Development 130 2003 6089 6099
113. F. Itoh, S. Itoh, M.J. Goumans, G. Valdimarsdottir, T. Iso, and G.P. Dotto Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells EMBO J 23 2004 541 551
114. A. Blokzijl, C. Dahlqvist, E. Reissmann, A. Falk, A. Moliner, and U. Lendahl Cross-talk between the Notch and TGF-β signaling pathways mediated by interaction of the Notch intracellular domain with Smad3 J Cell Biol 163 2003 723 728
115. A. Kikuchi Modulation of Wnt signaling by Axin and Axil Cytokine Growth Factor Rev 10 1999 255 265
116. E. Labbe, A. Letamendia, and L. Attisano Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and wnt pathways Proc Natl Acad Sci USA 97 2000 8358 8363
117. M. Nishita, M.K. Hashimoto, S. Ogata, M.N. Laurent, N. Ueno, and H. Shibuya Interaction between Wnt and TGF-β signaling pathways during formation of Spemann's organizer Nature 403 2000 781 785
118. S.M. Hussein, E.K. Duff, and C. Sirard Smad4 and β-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2 J Biol Chem 278 2003 48805 48814
119. D. Onichtchouk, Y.G. Chen, R. Dosch, V. Gawantka, H. Delius, and J. Massague Silencing of TGF-β signaling by the pseudoreceptor BAMBI Nature 401 1999 480 485
120. T. Sekiya, S. Adachi, K. Kohu, T. Yamada, O. Higuchi, and Y. Furukawa Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-β signaling, as a target of the β-catenin pathway in colorectal tumor cells J Biol Chem 279 2004 6840 6846
121. M. Kretzschmar, J. Doody, and J. Massague Opposing BMP and EGF signaling pathways converge on the TGF-β family mediator Smad1 Nature 389 1997 618 622
122. S. Mori, K. Matsuzaki, K. Yoshida, F. Furukawa, Y. Tahashi, and H. Yamagata TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions Oncogene 23 2004 7416 7429
123. E.M. Pera, A. Ikeda, E. Eivers, and E.M. De Robertis Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction Genes Dev 17 2003 3023 3028
124. J. Aubin, A. Davy, and P. Soriano In vivo convergence of BMP and MAPK signaling pathways: impact of differential Smad1 phosphorylation on development and homeostasis Genes Dev 18 2004 1482 1494
125. M.P. de Caestecker, W.T. Parks, C.J. Frank, P. Castagnino, D.P. Bottaro, and A.B. Roberts Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases Genes Dev 12 1998 1587 1592
126. M. Suzawa, Y. Tamura, S. Fukumoto, K. Miyazono, T. Fujita, and S. Kato Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation J Bone Miner Res 17 2002 240 248
127. Y. Tamura, Y. Takeuchi, M. Suzawa, S. Fukumoto, M. Kato, and K. Miyazono Focal adhesion kinase activity is required for bone morphogenetic protein-Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells J Bone Miner Res 16 2001 1772 1779
128. K. Nakashima, M. Yanagisawa, H. Arakawa, N. Kimura, T. Hisatsune, and M. Kawabata Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300 Science 284 1999 479 482
129. L. Ulloa, J. Doody, and J. Massague Inhibition of transforming growth factor-β/SMAD signaling by the interferon-gamma/STAT pathway Nature 397 1999 710 713
130. S. Kim, T. Koga, M. Isobe, B.E. Kern, T. Yokochi, and Y.E. Chin Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation Genes Dev 17 2003 1979 1991